MCID: SML008
MIFTS: 33

Small Intestine Lymphoma

Categories: Blood diseases, Cancer diseases, Gastrointestinal diseases, Immune diseases

Aliases & Classifications for Small Intestine Lymphoma

MalaCards integrated aliases for Small Intestine Lymphoma:

Name: Small Intestine Lymphoma 12 15 37
Small Intestinal Lymphoma 12 70

Classifications:



External Ids:

Disease Ontology 12 DOID:13996
NCIt 50 C4007
SNOMED-CT 67 449074003
UMLS 70 C0278805

Summaries for Small Intestine Lymphoma

MalaCards based summary : Small Intestine Lymphoma, also known as small intestinal lymphoma, is related to intestinal disease and alpha-heavy chain disease. An important gene associated with Small Intestine Lymphoma is SPAG11A (Sperm Associated Antigen 11A), and among its related pathways/superpathways are Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers and Primary immunodeficiency. The drugs Amoxicillin and Ciprofloxacin have been mentioned in the context of this disorder. Affiliated tissues include small intestine, liver and bone marrow.

Related Diseases for Small Intestine Lymphoma

Graphical network of the top 20 diseases related to Small Intestine Lymphoma:



Diseases related to Small Intestine Lymphoma

Symptoms & Phenotypes for Small Intestine Lymphoma

Drugs & Therapeutics for Small Intestine Lymphoma

Drugs for Small Intestine Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 158)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Amoxicillin Approved, Vet_approved Phase 3 26787-78-0 33613
2
Ciprofloxacin Approved, Investigational Phase 3 85721-33-1 2764
3 Orange Approved Phase 3
4
Dexamethasone Approved, Investigational, Vet_approved Phase 3 50-02-2 5743
5
Ondansetron Approved Phase 3 99614-02-5 4595
6
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 3 1177-87-3
7
Ofloxacin Approved Phase 3 82419-36-1 4583
8
Levofloxacin Approved, Investigational Phase 3 100986-85-4 149096
9
Guaifenesin Approved, Investigational, Vet_approved Phase 3 93-14-1 3516
10
Morphine Approved, Investigational Phase 3 57-27-2 5288826
11
Phenylpropanolamine Approved, Vet_approved, Withdrawn Phase 3 14838-15-4 26934
12
Dextromethorphan Approved Phase 3 125-71-3 5360696 5362449
13
Miconazole Approved, Investigational, Vet_approved Phase 3 22916-47-8 4189
14
Clotrimazole Approved, Vet_approved Phase 3 23593-75-1 2812
15
Caspofungin Approved Phase 3 179463-17-3, 162808-62-0 468682 2826718
16
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
17
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
18 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
19 Amoxicillin-Potassium Clavulanate Combination Phase 3
20 Clavulanic Acids Phase 3
21 beta-Lactamase Inhibitors Phase 3
22 Neurotransmitter Agents Phase 3
23 Psychotropic Drugs Phase 3
24 Gastrointestinal Agents Phase 3
25 Cola Phase 3
26 Hormones Phase 3
27 glucocorticoids Phase 3
28 Hormone Antagonists Phase 3
29 Antiemetics Phase 3
30 Liver Extracts Phase 3
31 Antineoplastic Agents, Hormonal Phase 3
32 Anti-Inflammatory Agents Phase 3
33 Antipsychotic Agents Phase 3
34 Anti-Anxiety Agents Phase 3
35 Anti-Bacterial Agents Phase 3
36 Cytochrome P-450 Enzyme Inhibitors Phase 3
37 Anti-Infective Agents Phase 3
38 Narcotics Phase 3
39 Respiratory System Agents Phase 3
40 Excitatory Amino Acid Antagonists Phase 3
41 Analgesics, Opioid Phase 3
42 Chlorpheniramine, phenylpropanolamine drug combination Phase 3
43 Analgesics Phase 3
44 Antitussive Agents Phase 3
45 Antifungal Agents Phase 3
46 Amebicides Phase 3
47 Antiparasitic Agents Phase 3
48 Liposomal amphotericin B Phase 3
49 Antiprotozoal Agents Phase 3
50 Anesthetics Phase 3

Interventional clinical trials:

(show top 50) (show all 67)
# Name Status NCT ID Phase Drugs
1 Study of the Relationship Between the Rate of Residual Platinum in the Blood and the Incidence of Persistent Neurotoxicity in Patients Treated for Gastrointestinal Cancer With Oxaliplatin Unknown status NCT00274885 Phase 4 oxaliplatin
2 A Prospective Randomised Phase III Trial of Early Hospital Discharge Versus Standard Inpatient Management of Cancer Patients With Low-Risk Febrile Neutropenia Receiving Oral Antibiotics. Oral Antibiotics for Neutropenic Sepsis Giving Early Hospital Discharge [ORANGE] Unknown status NCT00445497 Phase 3 amoxicillin-clavulanate potassium;ciprofloxacin
3 A Randomized Phase III Double-Blind Study Of Ondansetron And Dexamethasone Versus Ondansetron And Placebo In The Prophylaxis Of Radiation-Induced Emesis Completed NCT00016380 Phase 3 dexamethasone;ondansetron
4 A Randomized, Prospective Double-Blind, Placebo-Controlled Trial of Prophylactic Oral Levofloxacin Following Chemotherapy for Lymphoma and Solid Tumors Completed NCT00005590 Phase 3 levofloxacin
5 A Phase III Double-Blind Equivalence Study of Two Different Formulations of Slow-Release Morphine Followed by a Randomization Between Dextromethorphan or Placebo Plus Statex SR for Chronic Cancer Pain Relief in Terminally Ill Patients Completed NCT00003687 Phase 3 dextromethorphan hydrobromide;morphine sulfate
6 A Multicenter, Double-Blind, Randomized, Comparative Study To Evaluate The Safety, Tolerability, And Efficacy Of MK-0991 Versus (Amphotericin B) Liposome For Injection As Empirical Therapy In Patients With Persistent Fever And Neutropenia Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
7 Phase III, Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Ondansetron in the Control of Chronic Nausea and Vomiting Not Due to Antineoplastic Therapy in Patients With Advanced Cancer Completed NCT00006348 Phase 3 ondansetron
8 A Strategic Study to Determine the Optimal Moment to Initiate Systemic Antifungal Therapy With Ambisome in Granulocytopenic Cancer Patients With Unexplained Fever Refractory to Empirical Antibacterials Completed NCT00003938 Phase 3 liposomal amphotericin B
9 A Randomized, Double-blind, Placebo-controlled Multi-center Study to Evaluate the Safety and Efficacy of Fentanyl Sublingual Spray (Fentanyl SL Spray) for the Treatment of Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
10 A Phase II Evaluation of High Dose Chemotherapy and Autologous Stem Cell Transplantation for Intestinal T-cell Lymphomas Unknown status NCT00669812 Phase 2 carmustine;cyclophosphamide;cytarabine;doxorubicin hydrochloride;epirubicin hydrochloride;etoposide;ifosfamide;melphalan;methotrexate;prednisolone;vincristine sulfate
11 Purine-Analog-Containing Non-Myeloablative Allogeneic Stem Cell Transplantation for Treatment of Hematologic Malignancies and Severe Aplastic Anemia Completed NCT00006379 Phase 2 cyclophosphamide;fludarabine phosphate
12 Treatment of Patients With Hematological Malignancies Using Marrow Transplantation From Unrelated Donors Incompatible for One HLA Locus Antigen Completed NCT00005804 Phase 2 cyclophosphamide
13 A Phase I/II Study of Clofarabine in Patients With Relapsed T-Cell and NK-Cell Lymphomas Completed NCT00416351 Phase 1, Phase 2 clofarabine
14 A Pilot Phase I/II Trial of Enteral Wallstents for Colonic Obstruction in the Setting of Malignancy Completed NCT00004911 Phase 1, Phase 2
15 A Pilot Phase I/II Trial of Enteral Wallstents for Duodenal Obstruction in the Setting of Malignancy Completed NCT00004910 Phase 1, Phase 2
16 Octreotide for Palliation of Inoperable Bowel Obstruction: A Phase II Study Completed NCT00004895 Phase 2 octreotide acetate
17 Phase II Trial of Everolimus (RAD001) in Relapsed/Refractory Lymphoma Completed NCT00436618 Phase 2 Everolimus
18 Gem-CHOP: A Randomized Phase II Study of Gemcitabine Combined With CHOP in Untreated Aggressive Non-Hodgkin's Lymphoma Completed NCT00079261 Phase 2 CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;gemcitabine hydrochloride;prednisone;vincristine sulfate
19 Phase II Study of Weekly Administered High-Dose Pegylated Interferon Alfa-2B (PEGIntron) in Advanced Stage Low Grade Non-Hodgkin's Lymphoma Completed NCT00006039 Phase 2
20 Pilot Study of Intraperitoneal (IP) Therapy With Cisplatin or Carboplatin and Floxuridine (FUdR) as Consolidation for Ovarian and Gastrointestinal Malignancies Completed NCT00005049 Phase 2 carboplatin;cisplatin;floxuridine
21 A Phase II Study of Sirolimus, Tacrolimus and Thymoglobulin, as Graft-versus-Host Prophylaxis in Patients Undergoing Unrelated Donor Hematopoietic Cell Transplantation Completed NCT00589563 Phase 2 cyclophosphamide;etoposide;fludarabine phosphate;melphalan;methotrexate;sirolimus;tacrolimus
22 A Phase 2, Open-Label Study to Evaluate the Efficacy and Safety of Patient-Specific Immunotherapy, Recombinant Idiotype Conjugated to KLH (Id-KLH) and Administered With GM-CSF, in Patients With CNS Lymphoma Withdrawn NCT00621036 Phase 2 methotrexate;thiotepa
23 CHOP-Campath, A Pilot Study of CHOP Plus Campath for the Primary Treatment of ALK-ve Peripheral T Cell Lymphoma [CHOP-CAMPATH] Unknown status NCT00562068 Phase 1 cyclophosphamide;doxorubicin hydrochloride;prednisolone;vincristine sulfate
24 A Phase I Clinical And Pharmacological Study Of Pyroxamide (NSC 696085) In Patients With Advanced Malignancies Completed NCT00042900 Phase 1 pyroxamide
25 A Multidose Phase I Study of Oral CC5013, a Thalidomide Derivative, in Patients With Refractory Metastatic Cancer Completed NCT00031941 Phase 1 lenalidomide
26 A Phase I Trial of VNP4010M, A Novel Alkylating Agent for Patients With Advanced or Metastatic Cancer Completed NCT00025129 Phase 1 laromustine
27 A Phase I Study of ZD0473 and Doxil in Patients With Advanced Refractory Cancer Completed NCT00016172 Phase 1 pegylated liposomal doxorubicin hydrochloride;picoplatin
28 A Phase I Dose Escalation to Maximally Tolerated Dose Trial of 5-Azacytidine (5 AC, NSC 102816) in Combination With Sodium Phenylbutyrate (PB, NSC 657802) in Patients With Refractory Solid Tumors Completed NCT00005639 Phase 1 Azacitidine Injection;sodium phenylbutyrate
29 A Phase I Study of Intraperitoneal Oxaliplatin Alone and in Combination With Intraperitoneal Floxuridine and Leucovorin in Patients With Advanced Metastatic Cancer Confined to the Peritoneal Cavity Completed NCT00005860 Phase 1 floxuridine;leucovorin calcium;oxaliplatin
30 A Phase I Trial of EMD 121974 in Patients With Advanced or Metastatic Cancer Completed NCT00004258 Phase 1 cilengitide
31 A Phase I and Pharmacokinetic Study of Sequences of NSC 655649 (Rebeccamycin Analogue) and Cisplatin Without and With Granulocyte Colony-Stimulating Factor Support Every 21 Days Completed NCT00004189 Phase 1 becatecarin;cisplatin
32 A PHASE I TRIAL OF BUTYRATE AND GANCICLOVIR IN EBV-ASSOCIATED MALIGNANCIES Completed NCT00006340 Phase 1 arginine butyrate;ganciclovir
33 A Phase I, Multiple Dose Escalation Trial of Intravenous Humanized Anti-CD3 Antibody (HuM291) in Patients With CD3+ T-cell Lymphomas Completed NCT00006009 Phase 1
34 Phase I Clinical and Pharmacological Study of Suberoylanilide Hydroxamic Acid- SAHA (MSK390) in Patients With Advanced Solid Tumors Completed NCT00005634 Phase 1 vorinostat
35 Phase I Clinical Study of Every Three Week Irinotecan With Oral Capecitabine Given Twice Daily for Two Weeks Out of Three in Patients With Gastrointestinal and Other Solid Malignancies Completed NCT00003867 Phase 1 capecitabine;irinotecan hydrochloride
36 A PHASE I STUDY OF IRINOTECAN (CPT-11) WITH PHARMACOKINETIC MODULATION BY CYCLOSPORINE A AND PHENOBARBITAL Completed NCT00002759 Phase 1 cyclosporine;irinotecan hydrochloride;phenobarbital
37 A Phase I Clinical Trial To Assess The Safety And Efficacy Of Intraperitoneal PV701 Administrations In Patients With Advanced Or Recurrent Malignancy Largely Confined To The Peritoneal Cavity Completed NCT00055705 Phase 1
38 A Phase I Study Of Medi 522 In Patients With Advanced Tumors Completed NCT00049712 Phase 1
39 A Phase I Trial of VNP40101M, a Novel Alkylating Agent, Administered Weekly for Patients With Advanced or Metastatic Cancer Completed NCT00049699 Phase 1 laromustine
40 Pilot Study of Oxaliplatin in Combination With Capecitabine in Adult Cancer Patients Completed NCT00019773 Phase 1 capecitabine;oxaliplatin
41 A Phase I Study of Weekly Gemcitabine in Combination With Infusional 5-Fluorouracil and Oral Calcium Leucovorin in Adult Cancer Patients Completed NCT00019513 Phase 1 fluorouracil;gemcitabine hydrochloride;leucovorin calcium
42 A Phase I Trial of Daily Bolus Flavopiridol for Five Consecutive Days in Patients With Refractory Neoplasms Completed NCT00019344 Phase 1 alvocidib
43 A PHASE I STUDY OF THE COMBINATION OF CAI AND PACLITAXEL IN ADULT PATIENTS WITH REFRACTORY CANCERS OR LYMPHOMA Completed NCT00019019 Phase 1 carboxyamidotriazole;paclitaxel
44 A Phase I Study of BMS-247550 (NSC 710428) Given Weekly X 3 Every 4 Weeks in Patients With Advanced Malignancies Completed NCT00006221 Phase 1 ixabepilone
45 Phase I Study of T Cell Depleted (TCD) Partially Matched Related Donor (PMRD) Hematopoietic Stem Cell Transplantation for High Risk Hematologic Diseases Using Intense Pre and Post Transplant Immunosuppression and Megadose CD34 "Veto" Cells Completed NCT00004904 Phase 1 cladribine;cyclophosphamide;etoposide;methylprednisolone;tacrolimus
46 A Phase I Study Of 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17DMAG) With Evaluation Of Hsp90 Client Proteins In Subjects With Solid Tumors And Lymphomas Completed NCT00088868 Phase 1 alvespimycin hydrochloride
47 A Phase I Pharmacokinetic Study Of Epothilone B Analogue BMS-247550 (NSC 710428D) In Patients With Advanced Malignancies And Varying Levels Of Liver Dysfunction Completed NCT00049400 Phase 1 BMS-247550
48 Phase I Pharmacokinetic Trial of Thalidomide and Docetaxel: A Regimen Based on Anti-Angiogenic Therapeutic Principles Completed NCT00049296 Phase 1 docetaxel;thalidomide
49 An Open-Label Phase I Dose Escalation Trial To Evaluate The Safety And Pharmacokinetics Of Motexafin Gadolinium And Doxorubicin Chemotherapy In The Treatment Of Advanced Malignancies Completed NCT00036790 Phase 1 doxorubicin hydrochloride;motexafin gadolinium
50 A Phase I Study of an Oral Histone Deacetylase Inhibitor, MS-275, in Refractory Solid Tumors and Lymphomas Completed NCT00020579 Phase 1 entinostat

Search NIH Clinical Center for Small Intestine Lymphoma

Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Small Intestine Lymphoma cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Small Intestine Lymphoma:
Hematopoietic stem cells for treatment of hematologic malignancies
Embryonic/Adult Cultured Cells Related to Small Intestine Lymphoma:
Bone marrow-derived hematopoietic stem cells

Genetic Tests for Small Intestine Lymphoma

Anatomical Context for Small Intestine Lymphoma

MalaCards organs/tissues related to Small Intestine Lymphoma:

40
Small Intestine, Liver, Bone Marrow, Monocytes, Lymph Node

Publications for Small Intestine Lymphoma

Articles related to Small Intestine Lymphoma:

(show top 50) (show all 114)
# Title Authors PMID Year
1
Assessment of biomarkers influencing treatment success on small intestinal lymphoma in dogs. 61
32920923 2021
2
Free perforation of primary small bowel lymphoma in a patient with celiac sprue and dermatitis herpetiformis. 61
33107962 2020
3
Potential MR Enterography Features to Differentiate Primary Small Intestinal Lymphoma From Crohn Disease. 61
32755202 2020
4
Strongyloides stercoralis Hyperinfection Syndrome: A Neglected Cause of Abdominal Pain. 61
33133837 2020
5
Upfront Surgery for Small Intestinal Non-Hodgkin's Lymphoma. 61
32234940 2020
6
Clinicopathological Features, Treatment Strategy, and Prognosis of Primary Non-Hodgkin's Lymphoma of the Duodenum: A SEER Database Analysis. 61
32399459 2020
7
Double-Balloon Endoscopy-Assisted Balloon Dilation of Strictures Secondary to Small-Intestinal Lymphoma. 61
31288506 2020
8
Burkitt's lymphoma in pregnant woman: Difficult management of a rare case. 61
33191188 2020
9
Invited Commentary on "Spectral CT Imaging in the Differential Diagnosis of Small Bowel Adenocarcinoma From Primary Small Intestinal Lymphoma". 61
30967333 2019
10
Spectral CT Imaging in the Differential Diagnosis of Small Bowel Adenocarcinoma From Primary Small Intestinal Lymphoma. 61
30803898 2019
11
Primary small bowel lymphoma presenting as invagination. 61
30664435 2018
12
The role of surgical management in primary small bowel lymphoma: A single-center experience. 61
28751057 2017
13
Identification of Mucosa-Invading and Intravascular Bacteria in Feline Small Intestinal Lymphoma. 61
27627983 2017
14
Diagnosis and treatment for primary small intestinal lymphoma of 59 cases: a follow-up study. 61
26728023 2016
15
Male Syrian Hamsters Experimentally Infected with Helicobacter spp. of the H. bilis Cluster Develop MALT-Associated Gastrointestinal Lymphomas. 61
26348390 2016
16
Ileo-ileal Intussusception and Bowel Obstruction Caused by Plasmablastic Lymphoma of Small Bowel- A Rare Entity in Rare Location. 61
27134931 2016
17
Small intestinal lymphoma in a post-renal transplant patient: a rare case with late presentation. 61
23801239 2014
18
Norwich paediatric triad: malrotation, intussusception and small intestinal lymphoma. 61
25432904 2014
19
[A case of small intestinal lymphoma with ileus requiring surgery during chemotherapy]. 61
25731555 2014
20
Primary extranodal gastrointestinal lymphoma: a single center experience from southern Iran - report of changing epidemiology. 61
25204482 2014
21
Acute abdomen as the first presentation of a malignant lymphoma of the small intestine. 61
25102713 2014
22
Laparoscopic resection of synchronous gastric cancer and primary small intestinal lymphoma: a case report. 61
24876758 2014
23
Comparative study of intestinal tuberculosis and primary small intestinal lymphoma. 61
24764686 2014
24
Ileo-ileal intussusception caused by diffuse large B-cell lymphoma of the ileum. 61
24363540 2013
25
A case of ileal mucosa-associated lymphoid tissue lymphoma accompanied by luminal stricture and arterial spurting. 61
24365736 2013
26
[Ultrasonographic and general pathologic features assessment of small intestinal lymphoma]. 61
23827071 2013
27
Clinical outcome of non-surgical treatment for primary small intestinal lymphoma diagnosed with double-balloon endoscopy. 61
22946663 2013
28
Microscopic polyangiitis complicated with ileal involvement detected by double-balloon endoscopy: a case report. 61
23452722 2013
29
[Differential diagnosis of intestinal tuberculosis and primary small intestinal lymphoma using endoscopy and computerized tomography]. 61
23268270 2012
30
Widespread mismatch repair expression in feline small intestinal lymphomas. 61
22000951 2012
31
[Primary small intestinal lymphoma: epidemiological, histological and therapeutic transition in Tunisia]. 61
22450277 2012
32
[When gluten-free diet does not cure celiac disease]. 61
22667047 2012
33
Diagnostic algorithm to differentiate lymphoma from inflammation in feline small intestinal biopsy samples. 61
21149848 2011
34
[Clinicopathological features of small intestinal tumors]. 61
20716865 2010
35
Ultrasonographic evaluation of the muscularis propria in cats with diffuse small intestinal lymphoma or inflammatory bowel disease. 61
20102493 2010
36
[Experience of the diagnosis and treatment of primary small intestine lymphoma]. 61
20302754 2010
37
Clinical outcome in patients with small-intestinal non-Hodgkin lymphoma. 61
19672778 2009
38
Immunophenotypic and histologic classification of 50 cases of feline gastrointestinal lymphoma. 61
19261637 2009
39
Primary small intestinal lymphoma presenting as a groin abscess. 61
19568563 2009
40
[Double balloon endoscopy as a useful tool for the diagnosis and treatment of four cases of primary small intestinal lymphoma]. 61
17633101 2007
41
Primary gastrointestinal lymphoma--a clinicopathologic study. 61
17883049 2007
42
Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. 61
17119030 2006
43
Monitoring nonresponsive patients who have celiac disease. 61
16644460 2006
44
Should adults be screened for celiac disease? What are the benefits and harms of screening? 61
15825117 2005
45
[Establishment and characteristics of orthotopically transplanted model of human primary malignant small intestinal lymphoma in nude mice]. 61
15555333 2004
46
Coeliac disease is the most common cause of chronic diarrhoea in Iran. 61
15201579 2004
47
Primary small intestinal lymphoma without symptom diagnosed by colonoscopy. 61
12702058 2003
48
Localised extranodal non-Hodgkin's lymphoma of the gastrointestinal tract: Sheffield Lymphoma Group experience (1989-1998). 61
11251169 2001
49
[Comparative diagnostic value of data of intestinoscopy with biopsy obtained from different regions of the small intestine]. 61
11599264 2001
50
A clinicopathologic study of primary small intestine lymphoma: prognostic significance of mucosa-associated lymphoid tissue-derived lymphoma. 61
10640959 2000

Variations for Small Intestine Lymphoma

Expression for Small Intestine Lymphoma

Search GEO for disease gene expression data for Small Intestine Lymphoma.

Pathways for Small Intestine Lymphoma

Pathways related to Small Intestine Lymphoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.02 CD79A CD3E
2 10.2 CD79A CD3E

GO Terms for Small Intestine Lymphoma

Biological processes related to Small Intestine Lymphoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 defense response GO:0006952 8.96 SPAG11B SPAG11A
2 antimicrobial humoral immune response mediated by antimicrobial peptide GO:0061844 8.62 SPAG11B SPAG11A

Molecular functions related to Small Intestine Lymphoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 transmembrane signaling receptor activity GO:0004888 8.8 CD79A CD72 CD3E

Sources for Small Intestine Lymphoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Apr-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
Content
Loading form....